Pediatric formulations in clinical testing and the challenge of final market formulation

Abstract

Age-appropriate medicines are required to allow compliance with treatment and safe delivery of a pediatric drug product. As drug products for adults are often not suitable for use in children, new pediatric formulations must be specifi -cally developed.